Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats

Neuropeptides

Volumn 31, Issue 3, 1997, Pages 281-285

  Biro E ^a   Penke, B ^a   Telegdy, G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; OCTAPEPTIDE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; LEARNING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEDATION; TRANQUILIZING ACTIVITY;

ANIMALIA;

EID: 0030872302     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90060-3     Document Type: Article

References (32)

1. Barden M, Merand Y, Rouleau D, Moore S, Dockray G J, Dupont A R. Regional distribution of somatostatin and cholecystokinin-like immunoreactivity in rat and bovine brain. Peptides 1981; 2: 299-302.
2. Crawly J N. Neuronal cholecystokinin, ISI Atlas Pharmacol 1989; 96: 312.
3. Ravard S, Dourish C T. Cholecystokinin and anxiety. Trends Pharmacol Sci 1990; 11: 271-273.
4. De Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psychiatry 1989; 46: 511-517.
5. Bradwejn J, Koszycky D, Meteissian G. Cholecystokinintetrapeptide induces panic attack in patients with panic disorder. Can J Psychiatry 1990; 35: 83-85.
6. Harro J, Vasar E. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. Eur J Pharmacol 1991; 193: 379-381.
7. Horwell D C. Development of CCK-B antagonists. Neuropeptides 1991; 19: 57-64.
8. Woodruff G N, Hill D R, Boden P, Pinnock R, Singh L, Hughes J. Functional role of brain CCK receptors. Neuropeptides 1991; 19: 45-56.
9. Singh L, Lewis A S, Field M J, Hughes J, Woodruff G N. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA 1991; 88: 1130-1133.
10. Fekete M, Kádár T, Penke B, Kovács K, Telegdy G. Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in rats. J Neuronal Transm 1981; 50: 81-88.
11. Sheehan M J, Bellerache J S. Facilitation of GABA release by cholecystokinin and cerulein in rat cerebral cortex. Neuropeptides 1983; 3: 429-434.
12. Kochman R L, Grey T R, Hirsch J D. Cholecystokinin in vivo reduces binding to the rat hypothalamic beta-adrenergic sites. Peptides 1984; 5: 499-502.
13. Magnani M, Mantovani P, Pepeu G. Effect of cholecystokinin octapeptide and ceruletide on release of acethylcholine from cerebral cortex of the rat in vivo. Neuropharmacology 1984; 23: 1305-1309.
14. Harfstrand A, Fuxe K, Agnati L F. Evidence that intracisternal injections of cholecystokinin-8 counteracts the cardiovascular effects of inttacisternally injected adrenaline and neuropeptide Y in the alpha-chloralose anaesthetized rat. J Hypertens 1986; 4: 5251-5253.
15. Weller A, Blass E M. Behavioural evidence for cholecystokinin-opiate interactions in neonatal rats. Am J Physiol 1988; 255: R901-907
16. Ruggeri M, Ungerstedt A, Agnati L F, Mutt V, Harfstrand A, Fuxe K. Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anesthetized rat. Neurochem Int 1987; 10: 509-520.
17. Vickroy T W, Bianchi B R. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens. Neuropeptides 1989; 13: 43-50.
18. Kendrick K, Leng G, Higuchi T. Noradrenalin, dopamine and serotonin release in the paraventricular and supraoptic nuclei of the rat in response to intravenous cholecystokinin injections. J Neuroendocrinol 1991; 3: 139-144.
19. Pellegrino L J, Pellegrino A S, Cushman A J. Stereotactic atlas of the rat brain. New York: Plenum Press. 1979: 8-57
20. Pellow S, Chopin P, File S, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-167
21. Csonka E, Fekete M, Nagy G et al. Anxiogenic effect of cholecystokinin in rats. In: Peptides. New York: Walter de Gruyter and Company. 1988: 249-252.
22. Fekete M, Lengyel A, Hegedüs B et al. Further analysis of the effects of cholecystokinin octapeptide on avoidance behaviour in rats. Eur J Pharmacol 1984; 98: 79-91.
23. Fekete M, Szabó A, Balázs M, Penke B, Telegdy G. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active and conditioned feeding behaviour of rats. Acta Physiol Hung 1981; 58: 39-45.
24. Kádár T, Fekete M, Telegdy G. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide. Acta Physiol Hung 1981; 58: 269-274.
25. Fekete M, Bokor M, Penke B Telegdy G. Effects of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance behaviour in rats. Acta Physiol Hung 1982; 60: 57-63.
26. Fekete M, Bokor P, Penke B, Kovács K, Telegdy G. Effects of cholecystokinin octapeptide and its fragments on brain monoamines and plasma corticosterone. Neurochem Internat 1981; 3: 165-169.
27. Crawly J N. Cholecystokinin-dopamine interaction. Trends Pharmacol Sci 1991; 12: 232-236.
28. Telegdy G. Neuropeptides and brain function. Basle: Karger. 1987: 1-332.
29. Biró E, Tóth G, Telegdy G. Involvement of neurotransmitters in the anxiolytic-like action of atrial natriuretic peptide in rats. Neuropeptides 1995; 29: 215-220.
30. Biró E, Tóth G, Telegdy G. Effect of receptor blockers on brain natriuretic peptide and C-type natriuretic peptide caused anxiolytic state in rats. Neuropeptides 1996; 30: 59-65.
31. Kovács A, Telegdy G. Effects of CGRP on active avoidance behaviour in rats. Physiol Behav 1995; 58: 429-435.
32. Kovács A, Telegdy G. CGRP prevents electroconvulsive shock-induced amnesia in rats. Pharmacol Biochem Behav 1993; 47: 121-125.